ClinicalTrials.gov

What Is ClinicalTrials.gov? ClinicalTrials.gov is a publicly searchable registry of clinical studies conducted around the world, listing each study's design, eligibility criteria, locations, and, when available, its results. Every registered study receives a unique identifier, an NCT number, that researchers, regulators, and the public can use to look up a study's status and details at any point during or after the trial. The database was created to increase transparency in clinical research, making it harder for a sponsor to register a study and never disclose an unfavorable outcome, and it has since become one of the standard reference points anyone evaluating a clinical claim is likely to check first. How Does Clinical Trial Registration on ClinicalTrials.gov Work? Registering a study on ClinicalTrials.gov involves submitting detailed information about the study protocol, including the intervention being tested, the primary and secondary outcomes being measured, and the planned enrollment size, before the trial begins recruiting participants. Once a trial starts, researchers are generally required to keep the listing updated with its current recruitment status, and depending on the type of trial, to post summary results within a set window after the study concludes. This registration and reporting process is managed through the Protocol Registration and Results System, often referred to by its acronym in registration workflows. Which Studies Are Required to Register on ClinicalTrials.gov? Federal law requires registration for most interventional clinical trials involving a drug, biologic, or device that falls under FDA jurisdiction, particularly trials with U.S. sites or those supporting an FDA application. The specific registration requirements can be less clear-cut for other types of research, such as certain supplement studies or early-phase pilot studies, which is why sponsors often need guidance to determine whether a specific study falls under the mandate. Biotech clinical trials in particular tend to have registration obligations built into their regulatory strategy from the earliest planning stages, since noncompliance can affect a company's standing with the FDA. Why Does ClinicalTrials.gov Matter for Consumer Health and Biotech Brands? ClinicalTrials.gov matters because it's often the first place regulators, journalists, competitors, and increasingly informed consumers look to verify that a clinical claim is backed by a real, registered study rather than an informal internal test. A biotech or supplement brand that properly registers its trials and keeps the listing current signals a level of transparency and FDA compliance that builds credibility beyond what marketing copy alone can achieve. For companies preparing to eventually pursue publishing clinical trials in peer-reviewed literature, a clean ClinicalTrials.gov registration is often a prerequisite that journals check before accepting a manuscript. Common Examples of ClinicalTrials.gov in Practice A biotech company registers a Phase 2 drug trial on ClinicalTrials.gov before enrolling its first participant, as required for FDA submission.A supplement brand consults with regulatory counsel to determine whether its planned clinical study falls under the ClinicalTrials.gov registration mandate.A research team updates a trial's ClinicalTrials.gov listing to reflect a change in recruitment status partway through the study.A journalist looks up a company's clinical claim on ClinicalTrials.gov to confirm the underlying study was properly registered and its results reported. What ClinicalTrials.gov Means for Your Brand Understanding whether and how a study needs to be registered on ClinicalTrials.gov should be part of a brand's research planning from the start, not an afterthought handled once a trial is already underway. Brands that register proactively and keep their listings accurate build a public record of transparency that supports both regulatory compliance and long-term claim credibility. Partnering with a research team familiar with ClinicalTrials.gov's requirements helps a brand avoid the compliance risk and reputational cost of an incomplete or missing registration. Frequently Asked Questions What is ClinicalTrials.gov? ClinicalTrials.gov is a federally run, publicly searchable database where clinical studies are registered and, in many cases, their results are posted after completion. What is an NCT number? An NCT number is the unique identifier ClinicalTrials.gov assigns to each registered study, used to look up its details and status at any point. What trials must be registered on ClinicalTrials.gov? Most interventional trials involving a drug, biologic, or device under FDA jurisdiction, especially those with U.S. sites or supporting an FDA application, are required to register. Do supplement studies need to be registered on ClinicalTrials.gov? Whether a supplement study needs to register depends on its specific design and intent, since not all supplement research automatically falls under the federal registration mandate. Why is ClinicalTrials.gov important for consumer trust? ClinicalTrials.gov lets regulators, journalists, and consumers verify that a clinical claim is backed by a real, registered study rather than an unverified internal test. Do results have to be posted on ClinicalTrials.gov? Many registered trials are required to post summary results within a set timeframe after completion, depending on the type of study and its funding or regulatory status. Ready to build a clinical trial strategy that meets registration requirements? Talk to Citruslabs.